Fig. 1

Prediction and validation of RNAs associated with the regulation of stemness of ovarian cancer cells (A) a. Differential expression of LINC00665 in epithelial ovarian cancer versus normal tissues analyzed by TCGA TARGET GTEx. b. Relationship between LINC00665 and ovarian cancer prognosis analyzed by Kaplan–Meier plotter. c. Expression and cellular localization of LINC00665 in benign and malignant ovarian tumors detected by in situ hybridization. d. Differential expression of LINC00665 in OCSC and epithelial ovarian cancer cells detected by qPCR. (B) a. Differential expression of CNBP in epithelial ovarian cancer versus normal tissues analyzed by GENT2. b. The relationship between CNBP expression and ovarian cancer prognosis was analyzed by the Kaplan–Meier plotter. c. Differences in CNBP expression in samples from ovarian cancer of different clinical stages. d. Differences in CNBP expression between responders and non-responders. e. Expression and cellular localization of CNBP in benign and malignant ovarian tumors detected by immunohistochemical assays. f. The diagnostic value of ROC curve analysis of CNBP in epithelial ovarian cancer. g. Differential expression of CNBP protein in drug-resistant and sensitive ovarian cancer tissues (left) and the diagnostic value of ROC curve analysis of CNBP in chemotherapy resistance of ovarian cancer (right). h. Differences in the expression of CNBP mRNA and CNBP in OCSC and epithelial ovarian cancer cells detected by qPCR and western blotting, *P < 0.05